|
1
|
Ando K, Hamada K, Watanabe M, Ohkuma R,
Shida M, Onoue R, Kubota Y, Matsui H, Ishiguro T, Hirasawa Y, et
al: Plasma levels of soluble PD-L1 correlate with tumor regression
in patients with lung and gastric cancer treated with immune
checkpoint inhibitors. Anticancer Res. 39:5195–5201.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Badran YR, Cohen JV, Brastianos PK, Parikh
AR, Hong TS and Dougan M: Concurrent therapy with immune checkpoint
inhibitors and TNFα blockade in patients with gastrointestinal
immune-related adverse events. J Immunother Cancer.
7(226)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Fan Y and Moon JJ: Nanoparticle drug
delivery systems designed to improve cancer vaccines and
immunotherapy. Vaccines (Basel). 3:662–685. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Xiong Y, Wang Y and Tiruthani K: Tumor
immune microenvironment and nano-immunotherapeutics in colorectal
cancer. Nanomedicine. 21(102034)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Compton CC: Colorectal carcinoma:
Diagnostic, prognostic, and molecular features. Mod Pathol.
16:376–388. 2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Guinney J, Dienstmann R, Wang X, de
Reyniès A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda
G, Angelino P, et al: The consensus molecular subtypes of
colorectal cancer. Nat Med. 21:1350–1356. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Le DT, Uram JN, Wang H, Bartlett BR,
Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, et
al: PD-1 blockade in tumors with mismatch-repair deficiency. N Engl
J Med. 372:2509–2520. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Norton SE, Ward-Hartstonge KA, Taylor ES
and Kemp RA: Immune cell interplay in colorectal cancer prognosis.
World J Gastrointest Oncol. 7:221–232. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Laghi L, Bianchi P, Miranda E, Balladore
E, Pacetti V, Grizzi F, Allavena P, Torri V, Repici A, Santoro A,
et al: CD3+ cells at the invasive margin of deeply
invading (pT3-T4) colorectal cancer and risk of post-surgical
metastasis: A longitudinl study. Lancet Oncol. 10:877–884.
2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bindea G, Mlecnik B, Tosolini M,
Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T,
Lafontaine L, Berger A, et al: Spatiotemporal dynamics of
intratumoral immune cells reveal the immune landscape in human
cancer. Immunity. 39:782–795. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tanio A, Saito H, Uejima C, Takaya S,
Yamamoto M, Tokuyasu N, Sakamoto T, Honjo S, Ashida K and Fujiwara
Y: A prognostic index for colorectal cancer based on preoperative
absolute lymphocyte, monocyte, and neutrophil counts. Surg Today.
49:245–253. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kozak MM, von Eyben R, Pai JS, Anderson
EM, Welton ML, Shelton AA, Kin C, Koong AC and Chang DT: The
prognostic significance of pretreatment hematologic parameters in
patients undergoing resection for colorectal cancer. Am J Clin
Oncol. 4:405–412. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yang L, He W, Kong P, Jiang C, Yang Q, Xie
Q and Xia LP: Clinical baseline and prognostic difference of
platelet lymphocyte ratio (PLR) in right-sided and let-sided colon
cancers. BMC Cancer. 17(873)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hamilton SR and Aaltonen LA: Tumors of the
colon and rectum. In: World Health Organization Classification of
Tumors. Pathology and Genetics of Tumours of the Digestive System.
Lyon, IARC Press, pp103-104, 2000.
|
|
15
|
Lin Q, Wei Y, Ren L, Zhong Y, Qin C, Zheng
P, Xu P, Zhu D, Ji M and Xu J: Tumor deposit is a poor prognostic
indicator in patients who underwent simultaneous resection for
synchronous colorectal liver metastases. Onco Targets Ther.
8:233–240. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Therasse P, Arbuck SG, Eisenhauer EA,
Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van
Oosterom AT, Christian MC and Gwyther SG: New guidelines to
evaluate the response to treatment in solid tumors. J Natl Cancer
Inst. 92:205–216. 2000.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jakubowska K, Kisielewski W, Kańczuga-Koda
L, Koda M and Famulski W: Stromal and intraepithelial
tumour-infiltrating lymphocytes in colorectal carcinoma. Oncol
Lett. 14:6421–6432. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Salgado R, Denkert C, Demaria S, Sirtaine
N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL,
Penault-Llorca F, et al: The evaluation of tumour-infiltrating
lymphocytes (TILs) in breast cancer: Recommendations by an
International TILs working group 2014. Ann Oncol. 26:259–271.
2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Galon J, Pagès F, Marincola FM, Angell HK,
Thurin M, Lugli A, Zlobec I, Berger A, Bifulco C, Botti G, et al:
Cancer classification using the Immunoscore: A worldwide task
force. J Transl Med. 10(205)2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Mlecnik B, Tosolini M, Kirilovsky A,
Berger A, Bindea G, Meatchi T, Bruneval P, Trajanoski Z, Fridman
WH, Pagès F and Galon J: Histopathologic-based prognostic factors
of colorectal cancers are associated with the state of the local
immune reaction. J Clin Oncol. 29:610–618. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lam M, Tie J, Lee B, Desai J, Gibbs P and
Tran B: Systemic inflammation-impact on tumor biology and outcomes
in colorectal cancer. J Clin Cell Immunol. 6(377)2015.
|
|
22
|
Park JH, Powell AG, Roxburgh CS, Horgan
PG, McMillan DC and Edwards J: Mismatch repair status in patients
with primary operable colorectal cancer: Associations with the
local and systemic tumour environment. Br J Cancer. 114:562–570.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mori K, Toiyama Y, Saigusa S, Fujikawa H,
Hiro J, Kobayashi M, Ohi M, Araki T, Inoue Y, Tanaka K, et al:
Systemic analysis of predictive biomarkers for recurrence in
colorectal cancer patients treated with curative surgery. Dig Dis
Sci. 60:2477–2487. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Turner N, Wong HL, Templeton A, Tripathy
S, Whiti Rogers T, Croxford M, Jones I, Sinnathamby M, Desai J, Tie
J, et al: Analysis of local chronic inflammatory cell infiltrate
combined with systemic inflammation improves prognostication in
stage II colon cancer independent of standard clinicopathologic
criteria. Int J Cancer. 138:671–678. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wu B, Zhao S, Sheng Y, Ren L and Song G:
The prognostic value of combining the CD8+ lymphocyte
density and the circulating lymphocyte ratio in circumferential
resection margin biopsy in rectal cancer. Medicine (Baltimore).
97(e11972)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xiao B, Peng J, Zhang R, Xu J, Wang Y,
Fang Y, Lin J, Pan Z and Wu X: Density of CD8+ lymphocytes in
biopsy samples combined with the circulating lymphocyte ratio
predicts pathologic complete response to chemoradiotherapy for
rectal cancer. Cancer Manag Res. 9:701–708. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Afghahi A, Purington N, Han SS, Desai M,
Pierson E, Mathur MB, Seto T, Thompson CA, Rigdon J, Telli ML, et
al: Higher absolute lymphocyte counts predict lower mortality from
early-stage triple-negative breast cancer. Clin Cancer Res.
24:2851–2858. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lee KH, Kim EY, Yun JS, Park YL, Do SI,
Chae SW and Park CH: The prognostic and predictive value of
tumor-infiltrating lymphocytes and hematologic parameters in
patients with breast cancer. BMC Cancer. 18(938)2018.PubMed/NCBI View Article : Google Scholar
|
